3T Biosciences

3T Biosciences is an immunotherapy company focused on discovering and developing next-generation therapies with curative potential based on its immune-response-guided target discovery approach. The 3T-TRACE platform technology of 3T Biosciences is designed to overcome the challenges in advancing T-cell receptor (TCR)-based therapies. The company’s proprietary 3T-TRACETM platform technology leverages diverse target libraries and machine learning algorithms to identify and validate T-cell receptor (TCR) targets and specificities, revolutionizing target discovery and therapeutic development. By uncovering these novel targets, the company strives to create specific, safer, and more effective therapies for a broad patient population in urgent need of new treatments.